Yahoo
BSE - Delayed Quote INR

Cohance Lifesciences Limited (COHANCE.BO)

444.45 -36.90 (-7.67%)
At close: October 30 at 3:53:06 PM GMT+5:30
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Operating Cash Flow
--
3,683,200
6,733,500
3,847,700
4,571,958
Investing Cash Flow
--
-2,545,700
-3,897,000
-3,623,500
-1,950,056
Financing Cash Flow
--
-1,651,500
-3,274,000
-399,900
-2,419,512
End Cash Position
--
491,400
966,500
472,300
648,028
Capital Expenditure
--
-2,198,800
-3,168,000
-518,800
-2,859,122
Issuance of Capital Stock
--
324,300
88,000
--
--
Issuance of Debt
--
0
373,100
--
--
Repayment of Debt
--
-924,700
-110,800
-45,500
--
Free Cash Flow
--
1,484,400
3,565,500
3,328,900
1,712,836
3/31/2023 - 3/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: